CytomX Therapeutics (CTMX) Accounts Payables (2014 - 2026)
CytomX Therapeutics (CTMX) recorded Accounts Payables of $1.94 million in Q2 2026, up 754.2% from $227,000 a year earlier and up 41.7% from the prior quarter.
CytomX Therapeutics (CTMX) Accounts Payables (2014 - 2026) Analysis & Trends
At the end of FY2025, CytomX Therapeutics reported Accounts Payables of $1.3 million, up 19.6% from FY2024.
- Annual Accounts Payables has a five-year compound annual growth rate of -15.4% (FY2020 to FY2025).
- Across earlier years, Accounts Payables came in at $1.09 million in FY2024 (-25.4%), $1.46 million in FY2023 (-48.1%), $2.81 million in FY2022 (-0.3%) and $2.82 million in FY2021 (-5.9%).
- The Q2 2026 figure is the highest quarterly Accounts Payables since Q1 2024.
- On a year-over-year basis, Accounts Payables has increased for three consecutive quarters, with growth averaging 115.5% over the last eight quarters.
- Peak year-over-year performance for Accounts Payables in the last five years was growth of 754.2% in Q2 2026, against a decline of 85.9% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.37 million (Q1 2026), $1.3 million (Q4 2025) and $646,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | CytomX Therapeutics | 599.22 Mn | -358.44 Mn | - | 1.94 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.94 Mn |
| Mar 31, 2026 | 1.37 Mn |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 646,000.00 |
| Jun 30, 2025 | 227,000.00 |
| Mar 31, 2025 | 276,000.00 |
| Dec 31, 2024 | 1.09 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 611,000.00 |
| Mar 31, 2024 | 1.96 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | 1.71 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 2.20 Mn |
| Dec 31, 2022 | 2.81 Mn |
| Sep 30, 2022 | 5.18 Mn |
| Jun 30, 2022 | 1.92 Mn |
| Mar 31, 2022 | 1.72 Mn |
| Dec 31, 2021 | 2.82 Mn |
| Sep 30, 2021 | 1.52 Mn |
CytomX Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=CTMX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();